Latest Sense Stories

2011-01-06 10:00:00

CARLSBAD, Calif., Jan. 6, 2011 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at J.P. Morgan's 29th Annual Healthcare Conference on Thursday, January 13, 2011 at 8:00 a.m.

2011-01-04 07:00:00

CARLSBAD, Calif., Jan. 4, 2011 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announces the following webcast: What: Recent Advances in Isis' Development Pipeline Thursday, January 06, 2011 at 12:00 p.m. ET /9:00 When: a.m.

2011-01-04 06:15:00

HOERSHOLM, Denmark and SAN DIEGO, Jan. 4, 2011 /PRNewswire/ -- Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the research and development of mRNA and microRNA targeted therapies, and Pfizer Inc.

2010-12-15 14:40:43

The performance of a brain-machine interface designed to help paralyzed subjects move objects with their thoughts is improved with the addition of a robotic arm providing sensory feedback.

2010-12-15 14:27:54

Monkeys moved thought-controlled computer cursors more quickly and accurately when provided with additional sensory feedback.

2010-12-01 06:00:00

CARLSBAD, Calif., Dec. 1, 2010 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc.

2010-11-24 08:55:00

In a study in the Proceedings of the National Academy of Sciences journal, USC College's Emily Liman reveals what is behind all the puckering -- how people perceive sour flavors.

2010-11-23 06:00:00

CARLSBAD, Calif., Nov. 23, 2010 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc.

2010-11-16 22:14:57

New research indicates that the integration of senses and functions in the brain is common.

2010-11-16 06:00:00

CARLSBAD, Calif. and VANCOUVER, Canada, Nov. 16, 2010 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) and Xenon Pharmaceuticals Inc.